Avadel Pharmaceuticals plc

(NASDAQ:AVDL)

Latest On Avadel Pharmaceuticals plc (AVDL):

Date/Time Type Description Signal Details
2023-05-17 12:48 ESTNewsAvadel Pharmaceuticals: Lumryz Approved, Launch Expected June 2023 And We Remain BullishN/A
2023-05-04 21:04 ESTNewsAvadel Pharmaceuticals GAAP EPS of -$0.48 misses by $0.10N/A
2023-05-03 19:46 ESTNewsAvadel Pharmaceuticals' Strategic Moves To Conquer The Narcolepsy Market (Rating Upgrade)N/A
2023-05-01 18:02 ESTNewsAvadel gains 12% as FDA issues final approval for sleep therapyN/A
2023-04-19 19:06 ESTNewsAvadel: Sleeping Soundly, Why We're Giving A 'Buy' Rating Ahead Of Lumryz LaunchN/A
2023-04-01 06:51 ESTNewsAvadel Pharmaceuticals plc (AVDL) Q4 2022 Earnings Call TranscriptN/A
2023-03-30 23:36 ESTNewsAvadel Pharmaceuticals prices ADSs and Series B preferred shares offeringN/A
2023-03-30 23:36 ESTNewsAvadel Pharmaceuticals GAAP EPS of -$0.44 misses by $0.17N/A
2023-03-29 23:23 ESTNewsAvadel Pharma enters into royalty agreement with RTW investments for up to $75MN/A
2023-03-22 22:21 ESTNewsAvadel stock rises on FDA nod to import sleep disorder drug Lumryz ahead of potential approvalN/A
2023-03-12 15:40 ESTNewsAvadel Pharmaceuticals: Real-World Data Supports Market Opportunity For LumryzN/A
2023-03-07 14:48 ESTNewsNavigating Avadel's Potential And Risks With LumryzN/A
2023-03-02 11:50 ESTNewsAvadel requests final FDA approval for Lumyrz in narcolepsyN/A
2023-03-02 11:50 ESTNewsSenators introduce legislation to eliminate drug company loophole that delays competitionN/A
2023-02-25 02:43 ESTNewsAvadel seeks full FDA approval for sleep therapy as Jazz loses patent appealN/A
2022-12-09 12:50 ESTNewsAvadel And Jazz: The Oxybate Wars - Duking It OutN/A
2022-12-07 06:29 ESTNewsAvadel: Lumryz Overhang Now Removed, Rate BuyN/A
2022-11-30 11:51 ESTNewsAvadel surges 13% as Jefferies upgrades on opportunity to dent Jazz's market shareN/A
2022-11-19 02:02 ESTNewsAvadel Pharmaceuticals jumps on patent win in dispute with Jazz Pharma (update)N/A
2022-11-11 23:25 ESTNewsAvadel at eight-month high as FTC comments raise prospects for lead drugN/A
2022-11-09 18:40 ESTNewsAvadel Pharmaceuticals GAAP EPS of -$0.33 misses by $0.07N/A
2022-11-09 18:40 ESTNewsAvadel Pharmaceuticals plc (AVDL) Q3 2022 Earnings Call TranscriptN/A
2022-10-05 16:44 ESTNewsENPH, ATHX and AVDL among mid-day moversN/A
2022-09-06 20:37 ESTNewsAvadel's LUMRYZ: A Good Night's Sleep For Narcolepsy PatientsN/A
2022-09-05 11:33 ESTNewsAvadel Pharmaceuticals: Navigating Through The UncertaintyN/A
2022-09-01 00:30 ESTNewsAvadel Pharmaceuticals filed for 500M mixed shelf offeringN/A
2022-08-25 23:39 ESTNewsAvadel gains as judge delays hearing on patent dispute with Jazz PharmaN/A
2022-08-10 10:51 ESTNewsAvadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-09 16:29 ESTNewsAvadel Pharmaceuticals GAAP EPS of -$1.07 misses by $0.66N/A
2022-08-08 16:19 ESTNewsAvadel Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-07-19 12:00 ESTNewsAvadel stock rises 8% as FDA grants tentative approval to its Jazz's sleep disorder drug rivalN/A
2022-06-30 04:47 ESTNewsAvadel rises 18% as it expects tentative approval for sleep disorder drug; expects final approval by June 2023N/A
2022-06-17 06:54 ESTNewsAvadel: Further Delay, But Some Light At The End Of The TunnelN/A
2022-06-02 01:57 ESTNewsAvadel Pharmaceuticals reports insider transactions from Director, CEO & CFON/A
2022-05-27 14:51 ESTNewsAvadel spikes as Oppenheimer says selloff is overdoneN/A
2022-05-26 23:13 ESTNewsAvadel stock falls 26% as FDA cites patent issue in sleep disorder drug FT218 filing; expects tentative approval in 2023N/A
2022-05-26 23:13 ESTNewsJazz Pharmaceuticals benefitting from Avadel's daytime sleepiness drug delayN/A
2022-05-10 00:19 ESTNewsAvadel Pharmaceuticals GAAP EPS of -$0.45 misses by $0.02N/A
2022-05-10 00:19 ESTNewsAvadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q1 2022 Results - Earnings Call TranscriptN/A
2022-04-27 02:01 ESTNewsAvadel shares surge as company comments on recent trading activityN/A
2022-04-06 10:44 ESTNewsAvadel reports publication of data showing benefits of sleep disorder drug FT218N/A
2022-03-22 13:38 ESTNewsAvadel Pharmaceuticals Plc: Initiating Buy, Bye Bye To SleepinessN/A
2022-03-18 08:57 ESTNewsAvadel Pharmaceuticals GAAP EPS of -$0.38 beats by $0.03N/A
2022-03-18 08:57 ESTNewsAvadel Pharmaceuticals plc's (AVDL) CEO Gregory Divis on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-12 00:29 ESTNewsAvadel posts new efficacy and safety data for lead candidate in narcolepsyN/A
2021-11-09 01:43 ESTNewsAvadel Pharmaceuticals EPS beats by $0.01N/A
2021-11-09 01:43 ESTNewsAvadel records rising costs in Q3 amid plans to launch narcolepsy therapyN/A
2021-11-09 01:43 ESTNewsAvadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-05 19:20 ESTNewsAvadel Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-11-01 13:34 ESTNewsAvadel Pharmaceuticals: I Am HoldingN/A

About Avadel Pharmaceuticals plc (AVDL):

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. The company's lead product candidate is FT218, a formulation of sodium oxybate which is in a Phase 3 clinical trial for the treatment excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals PLC in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

AVDL Quotes by TradingView

See Advanced Chart

General

  • Name Avadel Pharmaceuticals plc
  • Symbol AVDL
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 32
  • Fiscal Year EndDecember
  • IPO Date1996-06-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.avadel.com
View More

Valuation

  • Trailing PE 71.85
  • Price/Sales (Trailing 12 Mt.) 11.79
  • Price/Book (Most Recent Quarter) 2.73
  • Enterprise Value Revenue 16.33
  • Enterprise Value EBITDA 37.99
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.32
  • Next Year EPS Estimate -$0.14
  • Next Quarter EPS Estimate -$0.25
  • Profit Margin 31%
  • Operating Margin -164%
  • Return on Assets -10%
  • Return on Equity 11%
  • Revenue 22.33 million
  • Earnings Per Share $0.13
  • Revenue Per Share $0.42
  • Gross Profit 16.59 million
  • Quarterly Earnings Growth -100%
View More

Highlights

  • Market Capitalization 546.06 million
  • EBITDA -38869000
  • PEG Ratio 0.07
  • Analyst Target Price $18.56
  • Book Value Per Share $2.78
View More

Share Statistics

  • Shares Outstanding 58.47 million
  • Shares Float 42.53 million
  • % Held by Insiders 589%
  • % Held by Institutions 56.94%
  • Shares Short 4.58 million
  • Shares Short Prior Month 3.77 million
  • Short Ratio 6.04
  • Short % of Shares Outstanding 8%
View More

Technicals

  • Beta 1.47
  • 52 Week High $12
  • 52 Week Low $4.83
  • 50 Day Moving Average 8.46
  • 200 Day Moving Average 6.8
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Avadel Pharmaceuticals plc (AVDL) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Avadel Pharmaceuticals plc (AVDL) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$N/A-$0.19-$0.2830.91%
2020-09-302020-11-09$N/A-$0.20-$0.2518.37%
2020-06-302020-08-10$N/A$0.49-$0.10578.05%
2020-03-312020-05-11$12.24 million-$0.02-$0.2391.21%
2019-12-312020-03-12$11 million-$0.07-$0.2672.73%
2019-09-302019-11-12$14.23 million-$0.24-$0.2711.11%
2019-06-302019-08-09$17.55 million-$0.23-$0.2920.69%
2019-03-312019-05-08$16.44 million-$0.35-$0.4928.57%
2018-12-312019-03-15$20.92 million-$1.72-$2.3426.5%
2018-09-302018-11-05$19.83 million-$0.43-$0.36-21.13%
2018-06-302018-08-07$29.23 million-$0.09-$0.3271.88%
2018-03-312018-05-02$33.29 million-$0.32-$0.3713.51%
2017-12-312018-03-08$34.41 million-$0.24-$0.3735.14%
2017-09-302017-11-08$39.68 million$0.52-$0.023071.43%
2017-06-302017-08-08$45.21 million$0.68$0.09684.31%
2017-03-312017-05-09$52.51 million$0.59$0.11436.36%
2016-12-312017-03-07$43.09 million$0.11-$0.37129.73%
2016-09-302016-11-07$32.09 million-$0.54-$0.23-134.78%
2016-06-302016-08-08$38.86 million-$0.48$0.06-900%
2016-03-312016-05-09$36.22 million-$0.15$0.14-207.14%
2015-12-312016-03-10$44.57 million$1.75$0.091844.44%
2015-09-302015-11-12$47.31 million-$0.73$0.23-417.39%
2015-06-302015-07-30$48.6 million-$0.43$0.40-207.5%
2015-03-312015-05-15$32.53 million$0.27$0.31-12.9%
2014-12-312015-03-19$2.97 million-$0.69-$0.17-305.88%
2014-09-302014-10-31$2.91 million-$0.26-$0.12-116.67%
2014-06-302014-07-29$4.32 million-$0.13-$0.09-44.44%
2014-03-312014-05-12$4.58 million-$0.60-$0.15-300%
2013-12-312014-03-06$6.18 million$0.20-$0.16225%
2013-09-302013-10-31$5.58 million-$0.25-$0.20-25%
2013-06-302013-07-29$5.54 million-$1.21-$0.27-348.15%
2013-03-312013-05-07$5.14 million-$0.35-$0.33-6.06%
2012-12-312013-02-28$7.31 million$0.46-$0.19342.11%
2012-09-302012-11-05$5.4 million-$0.26-$0.19-36.84%
2012-06-302012-07-25$6.03 million$0.25-$0.08412.5%
2012-03-312012-05-07$7.36 million-$0.19-$0.07-171.43%
2011-12-312012-03-14$8.65 million-$0.08$0.10-180%
2011-09-302011-11-02$10.43 million$0.07-$0.09177.78%
2011-06-302011-07-25$6.75 million-$0.14-$0.09-55.56%
2011-03-312011-05-09$6.76 million-$0.20-$0.11-81.82%
2010-12-312011-03-03$13.45 million$0.11$0.05120%
2010-09-302010-11-04$8.04 million-$0.14
2010-06-302010-07-28$7.52 million-$0.18-$0.05-260%
2010-03-312010-05-05$8.09 million-$0.17-$0.13-30.77%
2009-12-312010-03-08$10.59 million-$0.23-$0.10-130%
2009-09-302009-11-16$9.9 million-$0.14-$0.09-55.56%
2009-06-302009-08-05$9.58 million-$0.15-$0.10-50%
2009-03-312009-05-11$12.05 million$0.05-$0.14135.71%
2008-12-312009-03-04$9.47 million-$0.11-$0.02-450%
2008-09-302008-11-03$9.14 million-$0.10-$0.1741.18%
2008-06-302008-08-06$9.15 million-$0.14-$0.2544%
2008-03-312008-05-13$10.87 million-$0.15-$0.2948.28%
2007-12-312008-03-03$10.56 million-$0.23-$0.3330.3%
2007-09-302007-10-30$9.02 million-$0.38-$0.417.32%
2007-06-302007-08-01$7.45 million-$0.57-$0.28-103.57%
2007-03-312007-05-07$9.63 million-$0.38-$0.33-15.15%
2006-12-312007-03-07$7.78 million-$0.25-$0.3732.43%
2006-09-302006-11-01$5.41 million-$0.43-$0.38-13.16%
2006-06-302006-07-31$4.74 million-$0.40-$0.33-21.21%
2006-03-312006-05-03$5.1 million-$0.41-$0.31-32.26%
2005-12-312006-03-07$6.26 million-$0.28-$0.3417.65%
2005-09-302005-10-26$3.09 million-$0.50-$0.37-35.14%
2005-06-302005-07-27$6.14 million-$0.41-$0.39-5.13%
2005-03-312005-05-05$8.11 million$0.01-$0.03133.33%
2004-12-312005-03-11$18.72 million$0.28$0.31-9.68%
2004-09-302004-10-28$13.35 million$0.12$0.119.09%
2004-06-302004-07-29$8.99 million-$0.07$0.07-200%
2004-03-312004-04-29$14.35 million$0.18$0.03500%
2003-12-312004-03-11$11.27 million$0.08$0.04100%
2003-09-302003-10-30$5.37 million-$0.11$0.05-320%
2003-06-302003-07-30$5 million-$0.10$0.02-600%
2003-03-312003-04-30$3.53 million-$0.10$0.03-433.33%
1998-12-311999-02-23-$0.12-$0.10-20%
1998-09-301998-10-27-$0.17-$0.13-30.77%
1998-06-301998-07-31-$0.22-$0.18-22.22%
1997-12-311998-03-17$0.00-$0.15100%
1997-06-301997-07-31-$0.22-$0.248.33%
1996-12-311997-03-26-$0.15-$0.1816.67%

Avadel Pharmaceuticals plc (AVDL) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Avadel Pharmaceuticals plc (AVDL) Chart:

Avadel Pharmaceuticals plc (AVDL) News:

Below you will find a list of latest news for Avadel Pharmaceuticals plc (AVDL) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Avadel Pharmaceuticals plc (AVDL) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-04-172.50CALL0 0369.39TRUE00
2025-04-1750CALL0 0244.27TRUE00
2025-04-177.50.7CALL75 90253.93TRUE0.70
2025-04-17100.1CALL0 75768.32FALSE00
2025-04-1712.50.04CALL0 104196.28FALSE00
2025-04-17150CALL0 0241.11FALSE00
2025-04-172.50PUT0 0503.87FALSE00
2025-04-1750.1PUT0 802133.83FALSE00
2025-04-177.50.25PUT2 56966.21FALSE00
2025-04-17101.98PUT0 31494.11TRUE00
2025-04-1712.53.9PUT0 11206.59TRUE00
2025-04-17150PUT0 0133.84TRUE00
2025-05-162.50CALL0 0250.25TRUE00
2025-05-1653.62CALL0 2240.39TRUE00
2025-05-167.50CALL0 075.79TRUE00
2025-05-16100.35CALL0 8675.76FALSE00
2025-05-1612.50CALL0 078.53FALSE00
2025-05-16150CALL0 0151.18FALSE00
2025-05-1617.50CALL0 0173.3FALSE00
2025-05-162.50PUT0 0317.8FALSE00
2025-05-1650PUT0 084.68FALSE00
2025-05-167.50.54PUT10 875.85FALSE0.540
2025-05-16102.13PUT0 12073.63TRUE00
2025-05-1612.50PUT0 094TRUE00
2025-05-16150PUT0 0136.92TRUE00
2025-05-1617.50PUT0 0141.44TRUE00
2025-06-202.55.45CALL0 4116.93TRUE00
2025-06-2053.9CALL0 7974.72TRUE00
2025-06-207.51.3CALL10 86067.1TRUE1.30
2025-06-20100.51CALL2 320472.92FALSE0.510
2025-06-2012.50.33CALL0 73563.34FALSE00
2025-06-20150.19CALL0 257071.22FALSE00
2025-06-2017.50.25CALL0 225131.35FALSE00
2025-06-20200.35CALL0 91145.18FALSE00
2025-06-2022.50.15CALL0 25156.89FALSE00
2025-06-20250.1CALL0 22167.04FALSE00
2025-06-20300CALL0 0183.93FALSE00
2025-06-202.50.15PUT0 5242.4FALSE00
2025-06-2050.15PUT0 1471.17FALSE00
2025-06-207.50.66PUT0 25270.96FALSE00
2025-06-20102.45PUT2 49275.13TRUE2.450
2025-06-2012.55.07PUT0 15385.73TRUE00
2025-06-20154.8PUT0 4175.55TRUE00
2025-06-2017.50PUT0 0103.9TRUE00
2025-06-20200PUT0 0103.84TRUE00
2025-06-2022.50PUT0 0152.68TRUE00
2025-06-20250PUT0 0157.12TRUE00
2025-06-20300PUT0 0158.28TRUE00
2025-09-192.50CALL0 0179.17TRUE00
2025-09-1953.4CALL0 1174.72TRUE00
2025-09-197.52.15CALL0 1167.74TRUE00
2025-09-19100.85CALL40 28065.42FALSE-0.06-0.07
2025-09-1912.50.63CALL0 3067.67FALSE00
2025-09-19150.2CALL0 7165.43FALSE00
2025-09-1917.50CALL0 062.07FALSE00
2025-09-192.50PUT0 0168.69FALSE00
2025-09-1950.4PUT0 170.86FALSE00
2025-09-197.51.15PUT0 4167.82FALSE00
2025-09-19102.5PUT0 5266.72TRUE00
2025-09-1912.50PUT0 066.71TRUE00
2025-09-19150PUT0 079.74TRUE00
2025-09-1917.50PUT0 084.29TRUE00
2026-01-162.50CALL0 0147.65TRUE00
2026-01-1654.3CALL0 338107.37TRUE00
2026-01-167.52.33CALL0 30168.75TRUE00
2026-01-16101.47CALL5 886067.68FALSE1.470
2026-01-1612.50.9CALL0 74868.14FALSE00
2026-01-16150.8CALL0 265366.52FALSE00
2026-01-1617.50.55CALL0 95568.53FALSE00
2026-01-16200.3CALL0 26168.47FALSE00
2026-01-1622.50.8CALL0 15366.72FALSE00
2026-01-16251.6CALL0 4063.31FALSE00
2026-01-16300.4CALL0 3796.72FALSE00
2026-01-16350.4CALL0 1104.07FALSE00
2026-01-162.50PUT0 0131.23FALSE00
2026-01-1650.4PUT0 1271.19FALSE00
2026-01-167.51.85PUT0 59669.3FALSE00
2026-01-16103.12PUT2 68768.82TRUE3.120
2026-01-1612.55.54PUT0 13869.68TRUE00
2026-01-16157.76PUT0 100977.72TRUE00
2026-01-1617.50PUT0 091.19TRUE00
2026-01-16200PUT0 074.86TRUE00
2026-01-1622.50PUT0 0140.67TRUE00
2026-01-16250PUT0 0100.53TRUE00
2026-01-16300PUT0 0112.63TRUE00
2026-01-16350PUT0 0179.12TRUE00
2027-01-152.50CALL0 093.82TRUE00
2027-01-1554.1CALL0 11861.55TRUE00
2027-01-157.53.47CALL0 16467.04TRUE00
2027-01-15102.7CALL0 34861FALSE00
2027-01-1512.51.48CALL0 5661.95FALSE00
2027-01-15151.5CALL0 6061.56FALSE00
2027-01-1517.50.88CALL0 561.62FALSE00
2027-01-15201.85CALL0 4561.77FALSE00
2027-01-1522.50.89CALL0 2161.15FALSE00
2027-01-15250.41CALL0 2159.07FALSE00
2027-01-15300CALL0 062.28FALSE00
2027-01-152.50PUT0 0118.46FALSE00
2027-01-1551.25PUT0 464.44FALSE00
2027-01-157.52.6PUT0 1163.01FALSE00
2027-01-15104.1PUT0 1064.26TRUE00
2027-01-1512.55.86PUT0 463.33TRUE00
2027-01-15150PUT0 065.41TRUE00
2027-01-1517.56.9PUT0 172.75TRUE00
2027-01-15200PUT0 067.8TRUE00
2027-01-1522.50PUT0 064.73TRUE00
2027-01-15250PUT0 093.54TRUE00
2027-01-15300PUT0 079.08TRUE00

Latest AVDL Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST300$2.245
Jun 13, 2022 7:59 PM EST360$2.245
Jun 13, 2022 7:59 PM EST140$2.245
Jun 13, 2022 7:59 PM EST634$2.245
Jun 13, 2022 7:59 PM EST2$2.25

Avadel Pharmaceuticals plc (AVDL) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920080648/0001104659-20-080648-index.htm
2020-02-12UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1012477/000000000020001346/0000000000-20-001346-index.htm
2020-05-08UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1012477/000000000020004060/0000000000-20-004060-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000091068019000084/0000910680-19-000084-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1012477/000091957420001139/0000919574-20-001139-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1012477/000101247719000012/0001012477-19-000012-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1012477/000101247720000007/0001012477-20-000007-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1012477/000101247720000009/0001012477-20-000009-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1012477/000101247720000013/0001012477-20-000013-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465919062085/0001104659-19-062085-index.htm
2019-11-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465919066833/0001104659-19-066833-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465919068803/0001104659-19-068803-index.htm
2019-12-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000110465919069621/0001104659-19-069621-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000110465919069622/0001104659-19-069622-index.htm
2019-12-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465919070110/0001104659-19-070110-index.htm
2019-12-05SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1012477/000110465919070118/0001104659-19-070118-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000110465919070213/0001104659-19-070213-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000110465919070217/0001104659-19-070217-index.htm
2019-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465919071189/0001104659-19-071189-index.htm
2019-12-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465919072792/0001104659-19-072792-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465919073238/0001104659-19-073238-index.htm
2020-01-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1012477/000110465920001912/0001104659-20-001912-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920003111/0001104659-20-003111-index.htm
2020-02-05S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1012477/000110465920010987/0001104659-20-010987-index.htm
2020-02-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1012477/000110465920020153/0001104659-20-020153-index.htm
2020-02-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1012477/000110465920020407/0001104659-20-020407-index.htm
2020-02-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1012477/000110465920020410/0001104659-20-020410-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920024077/0001104659-20-024077-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920032146/0001104659-20-032146-index.htm
2020-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920037990/0001104659-20-037990-index.htm
2020-04-16PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1012477/000110465920047632/0001104659-20-047632-index.htm
2020-04-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1012477/000110465920051182/0001104659-20-051182-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920051350/0001104659-20-051350-index.htm
2020-04-28424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1012477/000110465920051827/0001104659-20-051827-index.htm
2020-04-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1012477/000110465920053562/0001104659-20-053562-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920053569/0001104659-20-053569-index.htm
2020-05-01S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1012477/000110465920055587/0001104659-20-055587-index.htm
2020-05-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1012477/000110465920058802/0001104659-20-058802-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920059095/0001104659-20-059095-index.htm
2020-06-16DEFR14ARevised definitive proxy soliciting materialshttps://www.sec.gov/Archives/edgar/data/1012477/000110465920073527/0001104659-20-073527-index.htm
2020-06-24424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1012477/000110465920076183/0001104659-20-076183-index.htm
2020-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920080648/0001104659-20-080648-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920082927/0001104659-20-082927-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920091513/0001104659-20-091513-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920092424/0001104659-20-092424-index.htm
2020-08-208-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920097315/0001104659-20-097315-index.htm
2020-08-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920100190/0001104659-20-100190-index.htm
2020-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1012477/000110465920104616/0001104659-20-104616-index.htm
2019-12-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911019012565/0001179110-19-012565-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911019012567/0001179110-19-012567-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911019012826/0001179110-19-012826-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020008889/0001179110-20-008889-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020008890/0001179110-20-008890-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020008891/0001179110-20-008891-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020008892/0001179110-20-008892-index.htm
2020-08-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020008893/0001179110-20-008893-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009023/0001179110-20-009023-index.htm
2020-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009024/0001179110-20-009024-index.htm
2020-08-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009054/0001179110-20-009054-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009083/0001179110-20-009083-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009084/0001179110-20-009084-index.htm
2020-08-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009086/0001179110-20-009086-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009461/0001179110-20-009461-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009462/0001179110-20-009462-index.htm
2020-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009709/0001179110-20-009709-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009877/0001179110-20-009877-index.htm
2020-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009879/0001179110-20-009879-index.htm
2020-09-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000117911020009897/0001179110-20-009897-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1012477/000119380520000194/0001193805-20-000194-index.htm
2020-03-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1012477/000121390020005412/0001213900-20-005412-index.htm
2019-12-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1012477/000149315219019859/0001493152-19-019859-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1012477/000149315220002411/0001493152-20-002411-index.htm
2019-11-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000156761919021621/0001567619-19-021621-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000156761919021625/0001567619-19-021625-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000156761919021875/0001567619-19-021875-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000156761919021885/0001567619-19-021885-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1012477/000156761919021887/0001567619-19-021887-index.htm
2020-02-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1012477/999999999520000371/9999999995-20-000371-index.htm
2020-05-12EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1012477/999999999520001129/9999999995-20-001129-index.htm

Avadel Pharmaceuticals plc (AVDL) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Avadel Pharmaceuticals plc (AVDL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 589%
Institutional Ownership: 5694%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-13THOMAS S MCHUGHChief Financial OfficerBuy10,000.007.7877,814.0010,000.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009086/0001179110-20-009086-index.htm
2020-09-16Mark Anthony McCamishDirectorBuy118,602.005.73679,968.99118,602.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009879/0001179110-20-009879-index.htm
2020-09-17Mark Anthony McCamishDirectorBuy52,398.005.83305,249.79171,000.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009879/0001179110-20-009879-index.htm
2020-08-28THOMAS S MCHUGHChief Financial OfficerBuy7,500.006.7750,776.5017,500.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009462/0001179110-20-009462-index.htm
2020-09-18THOMAS S MCHUGHChief Financial OfficerBuy4,000.006.0024,000.0021,500.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009897/0001179110-20-009897-index.htm
2019-11-15Geoffrey Michael GlassDirectorBuy5,000.004.9924,950.0032,900.00https://www.sec.gov/Archives/edgar/data/1012477/000156761919021887/0001567619-19-021887-index.htm
2019-12-03Linda PalczukDirectorBuy7,500.005.9144,325.0035,400.00https://www.sec.gov/Archives/edgar/data/1012477/000110465919070213/0001104659-19-070213-index.htm
2019-11-15Eric J EndeDirectorBuy10,000.004.9849,762.0037,900.00https://www.sec.gov/Archives/edgar/data/1012477/000156761919021875/0001567619-19-021875-index.htm
2020-08-14Linda PalczukDirectorBuy2,500.007.9419,849.7537,900.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009084/0001179110-20-009084-index.htm
2019-12-04Eric J EndeDirectorBuy10,000.005.9759,700.0047,900.00https://www.sec.gov/Archives/edgar/data/1012477/000110465919070217/0001104659-19-070217-index.htm
2019-11-18Geoffrey Michael GlassDirectorBuy15,000.004.9974,850.0047,900.00https://www.sec.gov/Archives/edgar/data/1012477/000156761919021887/0001567619-19-021887-index.htm
2020-08-12Geoffrey Michael GlassDirectorBuy6,500.007.7050,050.0054,400.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009054/0001179110-20-009054-index.htm
2019-12-12Sandra L HattenOfficerSell3,072.007.2322,210.5655,765.00https://www.sec.gov/Archives/edgar/data/1012477/000117911019012826/0001179110-19-012826-index.htm
2020-08-13Geoffrey Michael GlassDirectorBuy6,500.007.7650,440.0060,900.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009054/0001179110-20-009054-index.htm
2020-08-12Eric J EndeDirectorBuy15,000.007.76116,355.0062,900.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009024/0001179110-20-009024-index.htm
2020-08-13Eric J EndeDirectorBuy1,200.007.749,288.0064,100.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009083/0001179110-20-009083-index.htm
2020-08-28Geoffrey Michael GlassDirectorBuy4,800.006.7832,559.8465,700.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009461/0001179110-20-009461-index.htm
2020-08-13Eric J EndeDirectorBuy3,800.007.8029,640.0067,900.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009083/0001179110-20-009083-index.htm
2020-09-17Eric J EndeDirectorBuy17,000.005.7998,375.6084,900.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009877/0001179110-20-009877-index.htm
2019-11-15GREG J DIVISChief Executive OfficerBuy19,000.005.1397,470.0086,100.00https://www.sec.gov/Archives/edgar/data/1012477/000156761919021885/0001567619-19-021885-index.htm
2020-08-12Gregory J DivisChief Executive OfficerBuy13,000.007.78101,155.6099,100.00https://www.sec.gov/Archives/edgar/data/1012477/000117911020009023/0001179110-20-009023-index.htm